Latest progress and prospect of anti-inflammatory immunopharmacology in China
10.3867/j.issn.1000-3002.2016.12.010
- VernacularTitle:中国抗炎免疫药理学研究最新进展与展望
- Author:
Xiaohui LI
- Keywords:
inflammation;
immunopharmacology;
immune response;
regulatory T cells;
chromatin remodeling factors;
innate lymphoid cells;
drugs
- From:
Chinese Journal of Pharmacology and Toxicology
2016;30(12):1312-1315
- CountryChina
- Language:Chinese
-
Abstract:
Since the first session of Chinese anti-inflammatory immunopharmacological society in 1982,many breakthroughs of immunological research have been made in western countries,such as identification of pathogens by natural immune cells,regulation of immune response,lymphocyte differ?entiation and development. At the same time,much progress has been achieved in anti-inflammatory and immunological research in China,especially in the field of basic scientific issues in immunology, frontier and hot topics,immunological mechanisms of major diseases and related drugs. The course of development of Chinese anti- inflammatory immunopharmacological research has experiences various stages,such as ″follow ″ in the past to ″work together ″ and to ″lead ″ in some research areas in today′s international immunology.
